Fluoxetine dilates isolated small cerebral arteries of rats and attenuatesconstrictions to serotonin, norepinephrine, and a voltage-dependent Ca2+ channel opener
Z. Ungvari et al., Fluoxetine dilates isolated small cerebral arteries of rats and attenuatesconstrictions to serotonin, norepinephrine, and a voltage-dependent Ca2+ channel opener, STROKE, 30(9), 1999, pp. 1949-1954
Background and Purpose-Recent clinical observations question that the antid
epressant effect of fluoxetine (Prozac) can be explained solely with seroto
nin reuptake inhibition in the central nervous system, We hypothesized that
fluoxetine affects the tone of vessels and thereby modulates cerebral bloo
d flow.
Methods-A small branch of rat anterior cerebral artery (195 +/- 15 mu m in
diameter at 80 mm Hg perfusion pressure) was isolated, cannulated, and pres
surized (at 80 mm Hg), and changes in diameter were measured by videomicros
copy.
Results-Fluoxetine dilated small cerebral arteries with an EC50 of 7.7 +/-
1.0 x 10(-6) mol/L, a response that was not affected by removal of the endo
thelium or application of 4-aminopyridine (an inhibitor of aminopyridine-se
nsitive K+ channels), glibenclamide (an inhibitor of ATP-sensitive K+ chann
els), or tetraethylammonium (a nonspecific inhibitor of K+ channels). The p
resence of fluoxetine (10(-6) to 3 x 10(-5) mol/L) significantly attenuated
constrictions to serotonin (10(-9) to 10(-5) mol/L) and norepinephrine (10
(-9) to 10(-5) mol/L), Increasing concentrations of Bay K 8644 (a voltage-d
ependent Ca2+ channel opener, 10(-10) to 10(-6) mol/L) elicited constrictio
ns, which were markedly reduced by 2 x 10(-6) and 10(-5) mol/L fluoxetine,
whereas 3 x 10(-5) mol/L fluoxetine practically abolished the responses.
Conclusions-Fluoxetine elicits substantial dilation of isolated small cereb
ral arteries, a response that is not mediated by endothelium-derived dilato
r factors or activation of K+ channels. The finding that fluoxetine inhibit
s constrictor responses to Ca2+ channel opener, as well as serotonin and no
repinephrine, suggests that fluoxetine interferes with the Ca2+ signaling m
echanisms in the vascular smooth muscle. We speculate that fluoxetine incre
ases cerebral blood flow in vivo, which contributes to its previously descr
ibed beneficial actions in the treatment of mental disorders.